Results 41 to 50 of about 150,310 (246)
Immunity, Inflammation and Disease, 2021 Introduction CD4 count is an important predictor of disease progression, opportunities infection, deaths, and to understand the time interval between initial HIV infection to the first diagnosis.
Lekey khandu +2 more
doaj +1 more source
Mucocutaneous Manifestations in HIV-Infected Patients and Their Relationship to CD4 Lymphocyte Counts [PDF]
Scientifica, 2020 Background. More than 90% of human immunodeficiency virus- (HIV-) infected patients show at least one mucocutaneous manifestation during the course of their disease. The frequency, pattern, and associated factors of these complications vary among different populations. Objective.
Mina Mirnezami +4 more
openaire +3 more sources
Capillary blood as an alternative specimen for enumeration of percentages of lymphocyte subsets
BMC Research Notes, 2019 Objective Capillary blood has been increasingly used in point-of-care setting for clinical monitoring in immunology and infectious diseases. We explored whether percentages of lymphocyte subsets (T-cells; CD3+, helper T-cells; CD4+, cytotoxic T-cells ...
Supanart Srisala +5 more
doaj +1 more source
Frontiers in Neurology, 2020 Despite the undisputed benefits of combination antiretroviral therapy (cART), perinatally acquired human immunodeficiency virus (PHIV) children on treatment often present with a spectrum of neurological deficits known as HIV-associated neurocognitive ...
Antonio G. Lentoor
doaj +1 more source
Response to First-Line Antiretroviral Therapy Among PLHIV from a High-Risk, Low-Prevalence Setting
Journal of the International Association of Providers of AIDS Care, 2019 The study reports the response of first-line antiretroviral therapy (ART) by assessing CD4 and CD8 T-lymphocyte and viral load (VL) among Bangladeshi people living with HIV (PLHIV).
Shahria Mohammad Rashed Ul Islam M. Phil, MPH +3 more
doaj +1 more source
International Journal of Clinical Practice, 2023 Objective. To analyze the early changes in CD3+, CD4+, and CD8+T-cell subset counts in patients with sepsis and their correlation with prognosis to provide a feasible basis for clinical immunomodulation in sepsis. Methods.
Yanhua Li +4 more
doaj +1 more source
Local reference ranges for full blood count and CD4 lymphocyte count testing.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2009 Recent advances in full blood count and CD4 technology, coupled with the changing population demographics of the Gauteng region, have necessitated reevaluation of the reference ranges currently in use.A cross-sectional study of 631 female and 88 male HIV-negative participants from the Gauteng region was performed.
Lawrie, Denise +5 more
openaire +5 more sources
Canadian Journal of Infectious Diseases and Medical Microbiology, 2020 Purpose. With immunosuppressants being widely used, Pneumocystis jirovecii pneumonia (PCP) has been increasing and could be life-threatening among HIV-negative patients. This study aimed at identifying prognostic factors of PCP in patients with nephrotic
Yang Liu +3 more
doaj +1 more source
Evaluation of the probability of using total lymphocyte count as an alternative to CD4 count in initiation of art [PDF]
, 2014 Measurement of CD4+ T cell count in the diagnosis of HIV in a resource-constrain settings is often difficult due to high cost of equipments, reagents, and demand for trained personnel.
Okafor, PA, Tijjani, J
core +2 more sources
Evaluating total lymphocyte count as a surrogate marker for CD4 cell count in the management of HIV-infected patients in resource-limited settings: a study from China. [PDF]
PLoS ONE, 2013 OBJECTIVE: To evaluate the correlation of total lymphocyte count (TLC) and CD4 cell count and the suitability of TLC as a surrogate marker for CD4 cell count of HIV-infected patients in China.
Jieqing Chen +9 more
doaj +1 more source